Unilever is not ready to put its long-running consumer case against competitor Beiersdorf to rest, filing a challenge to a ruling that Beiersdorf did not make misleading claims about its Nivea clinical strength deodorant products.
Clive Palmer has lost a bid to overturn an order freezing more than $200 million in his personal assets in a case brought by the liquidators of collapsed Queensland Nickel.
The Full Court has denied a request by Sanofi that it review a judge’s refusal to block Alphapharm from listing its Semglee insulin injector pen on the PBS, calling the pharmaceutical giant’s appeal “misconceived”.
The Full Federal Court will issue its judgment Friday in French pharmaceutical giant Sanofi’s challenge to a judge’s refusal to block Alphapharm from listing an insulin injector pen on the PBS, just two weeks after the court heard arguments in the appeal.
The Full Court of the Federal Court has shot down a bid by the Victorian Government to intervene a second time in a long-running bargaining dispute between Esso Australia and three key Australian unions over its Bass Strait offshore oil and gas operations.
Critical emails from ASIC regarding a $250 million loan facility to Octaviar Group before its 2008 collapse were not only overlooked by the Public Trustee of Queensland in its role overseeing the firm’s finances but were wrongly deemed irrelevant by the judge that heard the case, the Full Federal Court was told.
Greens Senator Sarah Hanson-Young has slammed Liberal Democrat Senator David Leyonhjelm’s attempt to stay her defamation case against him without providing evidence that the alleged misandrist comments at the heart of the proceedings were spoken in Parliament.
Spotless Services is challenging a ruling that it owes redundancy to three workers employed at the Perth International Airport that were on fixed contracts.
AFT Pharmaceuticals has launched a partial challenge to a court ruling that its Maxigesic ads made a number of misleading claims, including that the drug provides stronger and more effective relief than Reckitt Benckiser’s Nuromol.
A judge won’t defer the opt-out notice in a shareholder class action against GetSwift pending the High Court’s decision on a special leave application to revive a competing class action, saying the sooner the case settles the better.